The menopause mess
Susan R. Johnson, MD, MS 1, 2 Our beliefs about menopause have been challenged by a series of randomized clinical trials, including the Women's Health Initiative (WHI), which have contradicted the results of observational studies which suggested hormone treatment as a "prevent all" for coronary heart disease, as well as several other common chronic diseases.
WHI has shown that estrogen plus progestin (E+P) has a different risk profile than estrogen only. Women in the study (who begin E+P at least 5 years after the final period) had increased risk for breast cancer, stroke, coronary heart disease, and pulmonary embolism. Follow up analyses have shown that the risk for breast cancer declines, and returns to baseline within 2 years of discontinuing E+P. Estrogen only, on the other hand, appears not to increase the risks of either heart disease or breast cancer, and there is some evidence that if started early in the menopause heart disease risk may be decreased.
The message, based on the WHI analyses to date, remains the same: while hormone treatment is the most effective way to treat vasomotor symptoms, its use for prevention of chronic disease in women over 60 is not recommended. 1 Because our understanding of the risks and benefits of hormone treatment remains a work in progress, clinicians should monitor future research. Two resources are the North American Menopause Society (NAMS)(http://www.menopause.org/), especially the position statements on menopause treatments, and the WHI (http://www.whi.org/), which includes summaries of new findings.
In the last decade we have also learned more about the menopause transition, the phase in which women move from reproductive age ovarian functioning to the final menstrual period. The Study of Women's Health Across the Nation (SWAN), is in its 11th year of data collection from a multi-ethnic cohort of over 3,000 women who were in their early 40's at the time the study began. SWAN seeks to better characterize the hormonal and symptom patterns of the transition, find a marker that will predict the final menstrual period, and determine factors that predict healthy aging.
